This blog focuses on EmbryoGlue® as there are now three Cochrane reviews showing improved clinical outcome when using this transfer medium, which contains a functional concentration of hyaluronan. The Number Needed to Treat (number of patients treated with EmbryoGlue to achieve an additional live birth) is reported to be around 17 patients, so perhaps the use of this specifically created transfer medium should not be considered an add-on, but rather a standard of care.
Dr. Mark Larman
Mark´s research on cryopreservation and IVF has taken him around the globe. After he completed his Post-doctoral studies in the UK he worked with Prof David Gardner in the US and Australia. Mark then returned to the US and is now CSO at Vitrolife.
Memoriam for Prof Michelle Lane
By Dr. Mark Larman, Feb 12, 2020
It is with great sadness that Vitrolife posts this memoriam for Prof Michelle Lane, who passed away last week.
When working with assisted reproduction we use a lot of different terms and definitions. This blog post will give you an update on the rather new acronym PGT (preimplantation genetic testing) as well as a glossary of common and useful terms.
Congratulations to a true embryo advocate
By Dr. Mark Larman, Oct 27, 2017